Rational engineering of recombinant modified vaccinia virus Ankara to enhance both innate and adaptive immunity for cancer immunotherapy

被引：0
|
作者：
Yang, N. [3 ]
Wang, Y. [3 ]
Liu, S. [3 ]
Luna, J. [1 ]
Rossi, A. [3 ]
Mazo, G. [3 ]
Tan, A. [2 ]
Wang, J. [4 ]
Yan, W. [5 ]
Choi, J. [5 ]
Xiang, J. [2 ]
Rice, C. [1 ]
Merghoub, T. [3 ]
Wolchok, J. [3 ]
Deng, L. [3 ]
机构：
[1] Rockefeller Univ, 1230 York Ave, New York, NY 10021 USA
[2] Weill Cornell Med, New York, NY USA
[3] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
[4] Genvira Biosci, Ottawa, ON, Canada
[5] IMVAQ Therapeut, Sammamish, WA USA
来源：
JOURNAL OF INVESTIGATIVE DERMATOLOGY | 2021年 / 141卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
697
引用
收藏
页码：S121 / S121
页数：1
相关论文
共 50 条
  • [41] Evaluation of recombinant modified vaccinia Ankara virus-based rhesus cytomegalovirus vaccines in rhesus macaques
    Yujuan Yue
    Zhongde Wang
    Kristina Abel
    Jinliang Li
    Lisa Strelow
    Angelo Mandarino
    Meghan K. Eberhardt
    Kimberli A. Schmidt
    Don J. Diamond
    Peter A. Barry
    Medical Microbiology and Immunology, 2008, 197 : 117 - 123
  • [42] Safety and Immunogenicity of Novel Recombinant BCG and Modified Vaccinia Virus Ankara Vaccines in Neonate Rhesus Macaques
    Rosario, Maximillian
    Fulkerson, John
    Soneji, Shamit
    Parker, Joe
    Im, Eung-Jun
    Borthwick, Nicola
    Bridgeman, Anne
    Bourne, Charles
    Joseph, Joan
    Sadoff, Jerald C.
    Hanke, Tomas
    JOURNAL OF VIROLOGY, 2010, 84 (15) : 7815 - 7821
  • [43] Vaccination with recombinant modified vaccinia virus Ankara protects against measles virus infection in the mouse and cotton rat model
    Weidinger, G
    Ohlmann, M
    Schlereth, B
    Sutter, G
    Niewiesk, S
    VACCINE, 2001, 19 (20-22) : 2764 - 2768
  • [44] Recombinant modified vaccinia virus Ankara-based vaccine induces protective immunity in mice against infection with influenza virus H5N1
    Kreijtz, Joost H. C. M.
    Suezer, Yasemin
    van Amerongen, Geert
    de Mutsert, Gerrie
    Schnierle, Barbara S.
    Wood, John M.
    Kuiken, Thijs
    Fouchier, Ron A. M.
    Loewer, Johannes
    Osterhaus, Albert D. M. E.
    Sutter, Gerd
    Rimmelzwaan, Guus F.
    JOURNAL OF INFECTIOUS DISEASES, 2007, 195 (11): : 1598 - 1606
  • [45] Erratum: Recombinant modified vaccinia virus Ankara expressing antigen 85A boosts BCG-primed and naturally acquired antimycobacterial immunity in humans
    H McShane
    A A Pathan
    C R Sander
    S M Keating
    S C Gilbert
    K Huygen
    H A Fletcher
    A V S Hill
    Nature Medicine, 2004, 10 : 1397 - 1397
  • [46] A West Nile virus recombinant protein vaccine that coactivates innate and adaptive immunity
    McDonald, William F.
    Huleatt, James W.
    Foellmer, Harald G.
    Hewitt, Duane
    Tang, Jie
    Desai, Priyanka
    Price, Albert
    Jacobs, Andrea
    Takahashi, Virginia N.
    Huang, Yan
    Nakaar, Valerian
    Alexopoulou, Lena
    Fikrig, Erol
    Powell, T. J.
    JOURNAL OF INFECTIOUS DISEASES, 2007, 195 (11): : 1607 - 1617
  • [47] Development of modified vaccinia Ankara-5T4 as specific immunotherapy for advanced human cancer
    Tykodi, Scott S.
    Thompson, John A.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2008, 8 (12) : 1947 - 1953
  • [48] Spontaneous and Targeted Mutations in the Decapping Enzyme Enhance Replication of Modified Vaccinia Virus Ankara (MVA) in Monkey Cells
    Erez, Noam
    Wyatt, Linda S.
    Americo, Jeffrey L.
    Xiao, Wei
    Moss, Bernard
    JOURNAL OF VIROLOGY, 2021, 95 (19)
  • [49] Anti-cathepsin D immunotherapy triggers both innate and adaptive anti-tumour immunity in breast cancer
    David, Timothee
    Mallavialle, Aude
    Faget, Julien
    Alcaraz, Lindsay B.
    Lapierre, Marion
    du Roure, Penelope Desroys
    Laurent-Matha, Valerie
    Mansouri, Hanane
    Jarlier, Marta
    Martineau, Pierre
    Roger, Pascal
    Guiu, Severine
    Chardes, Thierry
    Liaudet-Coopman, Emmanuelle
    BRITISH JOURNAL OF PHARMACOLOGY, 2024,
  • [50] Attenuated modified vaccinia virus Ankara can be used as an immunizing agent under conditions of preexisting immunity to the vector
    Ramírez, JC
    Gherardi, MM
    Rodríguez, D
    Esteban, M
    JOURNAL OF VIROLOGY, 2000, 74 (16) : 7651 - 7655
12345